The retinoblastoma protein is linked to the activation of Ras

Molecular and Cellular Biology

Volumn 19, Issue 11, 1999, Pages 7724-7732

  Lee, Kwang Youl ^a   Ladha, Mohamed H ^a   McMahon, Christine ^a   Ewen, Mark E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; FIBROBLAST; GENE ACTIVATION; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0000220411     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.11.7724     Document Type: Article

References (64)

1. Bader, D., T. Masaki, and D. A. Fischman. 1982. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95:763-770.
2. Barbacid, M. 1987. ras genes. Annu. Rev. Biochem. 56:779-827.
3. Bourne, H. R., D. A. Sanders, and F. McCormick. 1990. The GTPase superfamily: a conserved switch for diverse functions. Nature 348:125-132.
4. Brooks, R. F. 1977. Continuous protein synthesis is required to maintain the probability of entry into S phase. Cell 12:311-317.
5. Chen, P.-L., D. J. Riley, Y. Chen, and W.-H. Lee. 1996. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev. 10:2794-2804.
6. Chen, P.-L., D. J. Riley, S. Chen-Kiang, and W.-H. Lee. 1996. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc. Natl. Acad. Sci. USA 93:465-469.
7. Chen, P.-L., D. J. Riley, and W.-H. Lee. 1995. The retinoblastoma protein as a fundamental mediator of growth and differentiation signals. Crit. Rev. Eukaryot. Gene Expr. 5:79-95.
8. Clarke, A. R., E. R. Maandag, M. van Roon, N. M. T. van der Lugt, M. van der Valk, M. L. Hooper, A. Berns, and H. Riele. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359:328-330.
9. Coppola, J. A., B. A. Lewis, and M. D. Cole. 1990. Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types. Oncogene 5:1731-1733.
10. DeCaprio, J. A., J. W. Ludlow, J. Figge, J.-Y. Shew, C.-M. Huang, W.-H. Lee, E. Marsilio, E. Paucha, and D. M. Livingston. 1988. SV40 large T antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275-283.
11. Downward, J. 1997. Cell cycle: routine role for Ras. Curr. Biol. 7:R258-R260.
12. ras upon T-cell activation. Nature 346:719-723.
13. Dryja, T. P., J. Rapaport, T. L. McGee, T. M. Nork, and T. L. Schwartz. 1993. Molecular etiology of low-penetrance retinoblastoma in two pedigrees. Am. J. Genet. 52:1122-1128.
14. Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245-2262.
15. Dyson, N., K. Guida, K. Munger, and E. Harlow. 1989. The human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937.
16. Endo, T., and S. Goto. 1992. Retinoblastoma gene product Rb accumulates during myogenic differentiation and is deinduced by the expression of SV40 large T antigen. J. Biochem. 112:427-430.
17. Ewen, M. E. 1998. Regulation of the cell cycle by the Rb tumor suppressor family, p. 149-179. In M. Pagano (ed.), Cell cycle control, vol. 22. Springer-Verlag, Heidelberg, Germany.
18. Feig, L. A., and G. M. Cooper. 1988. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol. Cell. Biol. 8:3235-3243.
19. Gigure, V., S. Hollenberg, M. Rosenfeld, and R. Evans. 1980. Functional domains of the human glucocorticoid receptor. Cell 46:645-652.
20. Gu, W., J. W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-324.
21. Hock, J. R., A. Ziemiecki, R. Klemenz, R. Friis, and B. Groner. 1989. Oncogene mediated repression of glucocorticoid hormone response elements and glucocorticoid receptor levels. Cancer Res. 49:2266s-2274s.
22. Jacks, T., A. Fazeli, E. M. Schmitt, R. T. Bronson, M. A. Goodell, and R. A. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature 359:295-300.
23. Kitzmann, M., G. Carnac, M. Vandromme, M. Primig, N. J. C. Lamb, and A. Fernandez. 1998. The muscle regulatory factors MyoD and Myf-5 undergo distinct cell cycle-specific expression in muscle cells. J. Cell Biol. 142:1447-1459.
24. Val inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors. Mol. Cell. Biol. 15:5205-5213.
25. Kratzke, R. A., G. A. Otterson, A. Hogg, A. B. Coxon, J. Geradts, J. K. Cowell, and F. J. Kaye. 1994. Partial inactivation of RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors. Oncogene 9:1321-1326.
26. Ladha, M. H., K. Y. Lee, T. M. Upton, M. F. Reed, and M. E. Ewen. 1998. Regulation of exit from quiescence by p27 and cyclin D1-CDK4. Mol. Cell. Biol. 18:6605-6615.
27. Lee, E. Y.-H. P., C.-Y. Chang, N. Hu, Y.-C. J. Wang, C.-C. Lai, K. Herrup, W.-H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288-294.
28. Lee, E. Y.-H. P., N. Hu, S.-S. F. Yuan, L. A. Cox, A. Bradley, W.-H. Lee, and K. Herrup. 1994. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev. 8:2008-2021.
29. Leone, G., J. DeGregori, R. Sears, L. Jakoi, and J. R. Nevins. 1997. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387:422-426.
30. Lohmann, D. R., B. Brandt, W. Hopping, E. Passarge, and B. Horsthemke. 1994. Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma. Hum. Genet. 94:349-354.
31. Lu, X., and H. R. Horvitz. 1998. lin-35 and lin-53, two genes that antagonize a C. elegans Ras pathway, encode proteins similar to Rb and its binding protein RbAp48. Cell 95:981-991.
32. 1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:2600-2611.
33. Malumbres, M., and A. Pellicer. 1998. Ras pathways to cell cycle control and cell transformation. Front. Biosci. 3:d887-d912.
34. Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
35. Martelli, F., C. Cenciarelli, G. Santarelli, B. Polikar, A. Felsani, and M. Caruso. 1994. MyoD induces retinoblastoma gene expression during myogenic differentiation. Oncogene 1994:3579-3590.
36. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J.-Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
37. Mittnacht, S., H. Paterson, M. F. Olson, and C. J. Marshall. 1997. Ras signalling is required for inactivation of tumour suppressor pRb cell-cycle control protein. Curr. Biol. 7:219-221.
38. Novitch, B. G., G. J. Mulligan, T. Jacks, and A. B. Lassar. 1996. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J. Cell Biol. 135:441-456.
39. Novitch, B. G., D. B. Spicer, P. S. Kim, W. L. Cheung, and A. B. Lassar. 1999. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation. Curr. Biol. 9:449-459.
40. Olson, E. N., G. Spizz, and M. A. Tainsky. 1987. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol. Cell. Biol. 7:2104-2111.
41. Pardee, A. B. 1989. G1 events and regulation of cell proliferation. Science 246:603-608.
42. Paulus, W., I. Baur, F. M. Boyce, X. O. Breakefield, and S. A. Reeves. 1996. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J. Virol. 70:62-67.
43. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
44. Peeper, D. S., T. M. Upton, M. H. Ladha, E. Neuman, J. Zalvide. R. Bernards, J. A. DeCaprio, and M. E. Ewen. 1997. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386:177-181.
45. ras in receptor tyrosine kinase signalling. Biochim. Biophys. Acta 1198:131-147.
46. 1 phase in rodent fibroblasts. Genes Dev. 7:1559-1571.
47. Ramocki, M. B., S. E. Johnson, M. A. White, C. L. Ashendel, S. F. Konieczny, and E. J. Taparowsky. 1997. Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis. Mol. Cell. Biol. 17:3547-3555.
48. Raptis, L., H. L. Brownell, M. J. Corbley, K. W. Wood, D. Wang, and T. Haliotis. 1997. Cellular ras gene activity is required for full neoplastic transformation by the large tumor antigen of SV40. Cell Growth Differ. 8:891-901.
49. 1-to-S transition. Mol. Cell. Biol. 15:3463-3469.
50. Schlessinger, J., and D. Bar-Sagi. 1994. Activation of Ras and other signaling pathways by receptor tyrosine kinases. Cold Spring Harbor Symp. Quant. Biol. 59:173-179.
51. -/- muscle cells. Science 264:1467-1471.
52. Screpanti, V. A., M. Maroder, E. Petrangeli, L. Frati, and A. Gulino. 1989. Tumor-promoting phorbol ester and ras oncogene expression inhibit the glucocorticoid-dependent transcription from the mouse mammary tumor virus long terminal repeat. Mol. Endocrinol. 3:1659-1665.
53. Sellers, W. R., B. G. Novitch, S. Miyake, A. Heith, G. A. Otterson, F. J. Kaye, A. B. Lassar, and W. G. J. Kaelin. 1998. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor growth. Genes Dev. 12:96-106.
54. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
55. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
56. Sieburth, D. S., Q. Sun, and M. Han. 1998. SUR-8, a conserved Ras-binding protein with leucine-rich repeats, positively regulates Ras-mediated signaling in C. elegans. Cell 94:119-130.
57. Singh, P., J. Coe, and W. Hong. 1995. A role for the retinoblastoma protein in potentiating transcriptional activation of the glucocorticoid receptor. Nature 374:562-565.
58. Taylor, S. J., and D. Shalloway. 1996. Cell cycle-dependent activation of Ras. Curr. Biol. 6:1621-1627.
59. Todaro, G. J., and H. Green. 1963. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17:299-313.
60. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
61. Whitaker, L. L., H. Su, R. Baskaran, E. S. Knudsen, and J. Y. J. Wang. 1998. Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket. Mol. Cell. Biol. 18:4032-4042.
62. Wood, K. W., C. Sarnecki, T. M. Roberts, and J. Blenis. 1992. ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 68:1041-1050.
63. Zacksenhaus, E., Z. Jiang, D. Chung, J. D. Marth, R. A. Phillips, and B. L. Gallie. 1996. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10:3051-3064.
64. Zalvide, J., and J. A. DeCaprio. 1995. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell. Biol. 15:5800-5810.